1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,670 | 0,680 | 24.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | NSE - Motus GI Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 12.04. | Why Is Motus GI (MOTS) Stock Down 37% Today? | 6 | InvestorPlace | ||
| 11.04. | Motus GI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.03. | Motus GI Holdings files to sell 4.4M common shares for holders | 3 | Seeking Alpha | ||
| 18.03. | Motus GI GAAP EPS of -$4.48 misses by $0.29, revenue of $0.06M misses by $0.14M | 1 | Seeking Alpha | ||
| 18.03. | Motus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | 98 | GlobeNewswire (Europe) | Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process... ► Artikel lesen | |
| 18.03. | Motus GI Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 18.03. | Motus GI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.03. | Motus GI Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.02. | Motus GI raises $2.7M through warrant exercise, plans growth | 1 | Investing.com | ||
| 22.02. | Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds | 1 | GlobeNewswire (USA) | ||
| 21.02. | Motus GI Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.02. | Why Is Colonoscopy-Focused Motus GI Stock Trading Higher Today? | 2 | Benzinga.com | ||
| 21.02. | Motus GI secures new patent for endoscopic procedures | 2 | Investing.com | ||
| 21.02. | Motus GI Holdings, Inc.: Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu System to Avoid Clogging in Cleansing the GI Tract | 150 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. ("the "Company") (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences... ► Artikel lesen | |
| 16.02. | Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders | 5 | GlobeNewswire (USA) | ||
| 30.01. | Motus GI Holdings, Inc.: Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation | 151 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or "Motus GI" or "the Company"), a medical technology company focused on improving endoscopic outcomes... ► Artikel lesen | |
| 22.01. | Motus GI Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.12.23 | Motus GI Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.12.23 | Why Motus GI Holdings (MOTS) Shares Are Down 46% | 3 | Benzinga.com |
Seite:
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 73,99 | +0,19 % | Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity | According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, IRELAND / ACCESSWIRE... ► Artikel lesen | |
| INTUITIVE SURGICAL | 347,90 | +0,01 % | AKTIONÄR-Tipp Intuitive Surgical: Plus 50 Prozent seit Empfehlung - deswegen geht die Rally ... | Die positiven Nachrichten beim Marktführer in der roboterassistierten Chirurgie nehmen kein Ende. Nachdem der Konzern die Genehmigung für einen neuen Roboter von der US-Gesundheitsbehörde erhalten hatte... ► Artikel lesen | |
| ROKU | 58,65 | +0,20 % | Netflix Keeps Crashing on Roku TV | ||
| SERNOVA | 0,289 | -0,96 % | Sernova begrüßt den von Evotec nominierten Dr. Bernd Mühlenweg in seinem Board of Directors | - Dr. Daniel Mahony tritt von seinem Posten zurück, um sich neuen Aufgaben zu widmen
LONDON, ONTARIO; BOSTON, MASSACHUSETTS, den 22. April 2024 / IRW-Press / - Sernova Corp.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,446 | +1,69 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| INVIVO THERAPEUTICS HOLDINGS | 0,318 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| QUIDELORTHO | 36,800 | -0,54 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| ONTRAK | 0,323 | +3,36 % | Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical | NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 3,140 | -3,03 % | Tempest Therapeutics: Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications | TPST-1120, a first-in-class, oral, selective PPAR? antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data... ► Artikel lesen | |
| VERU | 1,206 | +5,98 % | Veru Inc.: Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 | ||
| CENTENE | 70,59 | +0,07 % | Centene-Aktie legt um 0,84 Prozent zu (71,0929 €) | Im Plus liegt aktuell das Wertpapier von Centene . Das Papier kostete zuletzt 75,78 US-Dollar. Heute hat sich an der US-amerikanischen Börse die Centene-Aktie zwischenzeitlich um 0,84 Prozent verteuert.... ► Artikel lesen | |
| SENSEONICS | 0,377 | -2,73 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| PATTERSON COMPANIES | 23,800 | -1,65 % | Dividendenbekanntmachungen (18.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,5706 USD 0,5347 EUR AKER ASA NO0010234552 15,5 NOK 1,3202 EUR ANORA GROUP OYJ FI4000292438 - 0... ► Artikel lesen | |
| EKSO BIONICS | 1,055 | -10,97 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 |
MOTUS GI HOLDINGS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,675 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
